Paul Dillon
Director of Facilities
What they build and who they serve.
Kanvas Biosciences develops microbiome mapping technology and live biotherapeutic products. Its HiPR-Map spatial imaging platform and Spectral Lightsheet microscope let researchers locate microbes inside the gut at high resolution, feeding a pipeline of immuno-oncology and gut-restoration drug candidates that include KAN-001 for solid-tumor patients who do not respond to immune checkpoint inhibitors.
Key people at the company—reach out on LinkedIn or email.
Paul Dillon
Director of Facilities
Steve Kujawa
Vice President of Business Development
Prateek Sehgal
Associate Director
Aditya Bhalla
Head of Process Development and Manufacturing
Kyle Jacoby
Vice President of Clinical Research
Lee Swem
Chief Development Officer
Hao Shi
Chief Technology Officer
Peter Diebold
Principal Scientist
Elisa Garabello
Research Intern
Kayla Waites
Senior Process Engineer
Signals from funding, traction, and product direction.
Rounds and investors over time, newest first.
Series A
Press, announcements, and coverage about this company.
Investors
Focus areas
We do not have indexed listings for Kanvas Biosciences right now. Roles may still be open on the company site—we will add them here when they appear in our feed.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job posts